Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subt

求助格式：
    【作者】（必须） Nan Song, PhD; Katherine L. Pogue-Geile, PhD; Patrick G. Gavin, BS; et al
    【文章标题】（必须）  Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes: Secondary ysis of NSABP C-07/NRG Oncology Randomized Clinical Trial.
    【期刊名，年份，卷（期），起止页*****】JAMA Oncol. 2016;2(9):1162-1169. doi:10.1001/jamaoncol.2016.2314
    【全文链接】  http://jamanetwork.com/journals/jamaoncology/article-abstract/2527366?utm_campaign=articlePDF&utm_medium=articlePDFlink&utm_source=articlePDF&utm_content=jamaoncol.2016.2314。

请给完整版的，本人已有Published online June 6, 2016 这个版本，这个版本中有需要打开的图表没有，需要链接，如Examination of time to recurrence for other individual subtypes revealed that stemlike subtype had the worst prognosis regardless of treatment as observed in the discovery cohort (eTable 12 in the Supplement).。
若无完整版，请勿认领。谢谢！